{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:46:27Z","timestamp":1790401587915,"version":"4.1.0"},"reference-count":74,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,10,30]],"date-time":"2016-10-30T00:00:00Z","timestamp":1477785600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004794","name":"Centre National de la Recherche Scientifique","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015872","name":"Universit\u00e9 de Lille","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015872","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004963","name":"Seventh Framework Programme","doi-asserted-by":"publisher","award":["602080"],"award-info":[{"award-number":["602080"]}],"id":[{"id":"10.13039\/501100004963","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013340","name":"Institute Pasteur De Lille","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013340","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000923","name":"Australian Research Council","doi-asserted-by":"publisher","award":["CE140100011"],"award-info":[{"award-number":["CE140100011"]}],"id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001791","name":"Griffith University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001791","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1027369"],"award-info":[{"award-number":["1027369"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1074016"],"award-info":[{"award-number":["APP1074016"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1093378"],"award-info":[{"award-number":["APP1093378"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.ijpddr.2016.12.005","type":"journal-article","created":{"date-parts":[[2016,12,23]],"date-time":"2016-12-23T22:15:25Z","timestamp":1482531325000},"page":"42-50","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":97,"title":["Effect of clinically approved HDAC inhibitors on Plasmodium, Leishmania and Schistosoma parasite growth"],"prefix":"10.1016","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3891-1913","authenticated-orcid":false,"given":"Ming Jang","family":"Chua","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan S.J.","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Lancelot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2699-7219","authenticated-orcid":false,"given":"Suzanne","family":"Lamotte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald F.","family":"Sp\u00e4th","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Prina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9820-8608","authenticated-orcid":false,"given":"Raymond J.","family":"Pierce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David P.","family":"Fairlie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina S.","family":"Skinner-Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine T.","family":"Andrews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ijpddr.2016.12.005_bib1","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ijpddr.2014.02.002","article-title":"Drug repurposing and human parasitic protozoan diseases","volume":"4","author":"Andrews","year":"2014","journal-title":"Int. J. Parasitol. Drugs Drug Resist"},{"issue":"2","key":"10.1016\/j.ijpddr.2016.12.005_bib2","doi-asserted-by":"crossref","first-page":"e31847","DOI":"10.1371\/journal.pone.0031847","article-title":"Comparative gene expression profiling of P.\u00a0falciparum malaria parasites exposed to three different histone deacetylase inhibitors","volume":"7","author":"Andrews","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ijpddr.2016.12.005_bib3","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/icb.2011.97","article-title":"HDAC inhibitors in parasitic diseases","volume":"90","author":"Andrews","year":"2012","journal-title":"Immunol. Cell Biol."},{"issue":"24","key":"10.1016\/j.ijpddr.2016.12.005_bib4","first-page":"3467","article-title":"Towards histone deacetylase inhibitors as new antimalarial drugs","volume":"18","author":"Andrews","year":"2012","journal-title":"Curr. Pharm. Des."},{"issue":"4","key":"10.1016\/j.ijpddr.2016.12.005_bib5","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1128\/AAC.00757-07","article-title":"Potent antimalarial activity of histone deacetylase inhibitor analogues","volume":"52","author":"Andrews","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"issue":"7","key":"10.1016\/j.ijpddr.2016.12.005_bib6","doi-asserted-by":"crossref","first-page":"4361","DOI":"10.1128\/AAC.02948-15","article-title":"Adaption of the [3H]-hypoxanthine uptake assay for in\u00a0vitro cultured Plasmodium knowlesi malaria parasites","volume":"60","author":"Arnold","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"issue":"5","key":"10.1016\/j.ijpddr.2016.12.005_bib7","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/nrd3674","article-title":"Epigenetic protein families: a new frontier for drug discovery","volume":"11","author":"Arrowsmith","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"issue":"4","key":"10.1016\/j.ijpddr.2016.12.005_bib8","doi-asserted-by":"crossref","first-page":"e2154","DOI":"10.1371\/journal.pntd.0002154","article-title":"High content analysis of primary macrophages hosting proliferating Leishmania amastigotes: application to anti-leishmanial drug discovery","volume":"7","author":"Aulner","year":"2013","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"Database issue","key":"10.1016\/j.ijpddr.2016.12.005_bib9","doi-asserted-by":"crossref","first-page":"D539","DOI":"10.1093\/nar\/gkn814","article-title":"PlasmoDB: a functional genomic database for malaria parasites","volume":"37","author":"Aurrecoechea","year":"2009","journal-title":"Nucleic Acids Res."},{"issue":"2","key":"10.1016\/j.ijpddr.2016.12.005_bib10","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/bies.201400145","article-title":"Multiple dimensions of epigenetic gene regulation in the malaria parasite Plasmodium falciparum: gene regulation via histone modifications, nucleosome positioning and nuclear architecture in P.\u00a0falciparum","volume":"37","author":"Ay","year":"2015","journal-title":"Bioessays"},{"issue":"3","key":"10.1016\/j.ijpddr.2016.12.005_bib11","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.exppara.2008.11.010","article-title":"Schistosoma mansoni: developmental arrest of miracidia treated with histone deacetylase inhibitors","volume":"121","author":"Azzi","year":"2009","journal-title":"Exp. Parasitol."},{"issue":"16","key":"10.1016\/j.ijpddr.2016.12.005_bib74","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1002\/jcc.20292","article-title":"Integrated Modeling Program, Applied Chemical Theory (IMPACT)","volume":"26","author":"Banks","year":"2005","journal-title":"J. Comput. Chem."},{"issue":"4","key":"10.1016\/j.ijpddr.2016.12.005_bib12","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1128\/AAC.04231-14","article-title":"Experimental resistance to drug combinations in Leishmania donovani: metabolic and phenotypic adaptations","volume":"59","author":"Berg","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"issue":"3","key":"10.1016\/j.ijpddr.2016.12.005_bib13","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.pharmthera.2014.04.004","article-title":"Histone deacetylase inhibitor (HDACI) mechanisms of action: emerging insights","volume":"143","author":"Bose","year":"2014","journal-title":"Pharmacol. Ther."},{"issue":"4","key":"10.1016\/j.ijpddr.2016.12.005_bib14","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.ccell.2016.03.007","article-title":"Exploiting the epigenome to control cancer-promoting gene-expression programs","volume":"29","author":"Brien","year":"2016","journal-title":"Cancer Cell."},{"issue":"1","key":"10.1016\/j.ijpddr.2016.12.005_bib15","doi-asserted-by":"crossref","first-page":"e1000737","DOI":"10.1371\/journal.ppat.1000737","article-title":"Histone deacetylases play a major role in the transcriptional regulation of the Plasmodium falciparum life cycle","volume":"6","author":"Chaal","year":"2010","journal-title":"PLoS Pathog."},{"issue":"8","key":"10.1016\/j.ijpddr.2016.12.005_bib16","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1111\/cmi.12471","article-title":"Host-parasite interactions: an intimate epigenetic relationship","volume":"17","author":"Cheeseman","year":"2015","journal-title":"Cell Microbiol."},{"issue":"4","key":"10.1016\/j.ijpddr.2016.12.005_bib17","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s00280-012-1940-9","article-title":"Characterizing the disposition, metabolism, and excretion of an orally active pan-deacetylase inhibitor, panobinostat, via trace radiolabeled 14C material in advanced cancer patients","volume":"70","author":"Clive","year":"2012","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"2","key":"10.1016\/j.ijpddr.2016.12.005_bib18","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.chom.2014.06.014","article-title":"A\u00a0Plasmodium falciparum histone deacetylase regulates antigenic variation and gametocyte conversion","volume":"16","author":"Coleman","year":"2014","journal-title":"Cell Host Microbe"},{"issue":"9936","key":"10.1016\/j.ijpddr.2016.12.005_bib19","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1016\/S0140-6736(13)61949-2","article-title":"Human schistosomiasis","volume":"383","author":"Colley","year":"2014","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ijpddr.2016.12.005_bib20","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1128\/CMR.19.1.111-126.2006","article-title":"Drug resistance in leishmaniasis","volume":"19","author":"Croft","year":"2006","journal-title":"Clin. Microbiol. Rev."},{"issue":"23","key":"10.1016\/j.ijpddr.2016.12.005_bib21","doi-asserted-by":"crossref","first-page":"13143","DOI":"10.1073\/pnas.93.23.13143","article-title":"Apicidin: a novel antiprotozoal agent that inhibits parasite histone deacetylase","volume":"93","author":"Darkin-Rattray","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5","key":"10.1016\/j.ijpddr.2016.12.005_bib22","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1056\/NEJMoa0808859","article-title":"Artemisinin resistance in Plasmodium falciparum malaria","volume":"361","author":"Dondorp","year":"2009","journal-title":"NEJM"},{"issue":"8","key":"10.1016\/j.ijpddr.2016.12.005_bib23","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.pt.2013.05.005","article-title":"Artemisinin resistance is a clear and present danger","volume":"29","author":"Dondorp","year":"2013","journal-title":"Trends Parasitol."},{"issue":"10","key":"10.1016\/j.ijpddr.2016.12.005_bib24","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.1128\/AAC.00439-08","article-title":"Antimalarial activity of phenylthiazolyl-bearing hydroxamate-based histone deacetylase inhibitors","volume":"52","author":"Dow","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.ijpddr.2016.12.005_bib25","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.molbiopara.2009.06.001","article-title":"Histone deacetylase inhibitors induce apoptosis, histone hyperacetylation and up-regulation of gene transcription in Schistosoma mansoni","volume":"168","author":"Dubois","year":"2009","journal-title":"Mol. Biochem. Parasitol."},{"issue":"5","key":"10.1016\/j.ijpddr.2016.12.005_bib26","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.1128\/AAC.00021-16","article-title":"From drug screening to target deconvolution: a target-based drug discovery pipeline using leishmania casein kinase 1 isoform 2 to identify compounds with antileishmanial activity","volume":"60","author":"Durieu","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"issue":"3","key":"10.1016\/j.ijpddr.2016.12.005_bib27","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ijpddr.2015.05.004","article-title":"Profiling the anti-protozoal activity of anti-cancer HDAC inhibitors against Plasmodium and Trypanosoma parasites","volume":"5","author":"Engel","year":"2015","journal-title":"Int. J. Parasitol. Drugs Drug Resist"},{"key":"10.1016\/j.ijpddr.2016.12.005_bib28","series-title":"Assessment Report: Farydak","author":"European Medicines Agency","year":"2015"},{"issue":"9","key":"10.1016\/j.ijpddr.2016.12.005_bib29","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrd4360","article-title":"Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders","volume":"13","author":"Falkenberg","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.ijpddr.2016.12.005_bib30","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cell.2005.01.037","article-title":"Telomeric heterochromatin propagation and histone acetylation control mutually exclusive expression of antigenic variation genes in malaria parasites","volume":"121","author":"Freitas-Junior","year":"2005","journal-title":"Cell"},{"issue":"17","key":"10.1016\/j.ijpddr.2016.12.005_bib31","first-page":"4916","article-title":"FK228 (depsipeptide) as a natural prodrug that inhibits class I histone deacetylases","volume":"62","author":"Furumai","year":"2002","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.ijpddr.2016.12.005_bib32","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s40265-015-0388-8","article-title":"Panobinostat: first global approval","volume":"75","author":"Garnock-Jones","year":"2015","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.ijpddr.2016.12.005_bib33","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/nrd2227","article-title":"Vorinostat","volume":"6","author":"Grant","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"issue":"5","key":"10.1016\/j.ijpddr.2016.12.005_bib34","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/cmi.12275","article-title":"Human red blood cell-adapted Plasmodium knowlesi parasites: a new model system for malaria research","volume":"16","author":"Gruring","year":"2014","journal-title":"Cell Microbiol."},{"issue":"6","key":"10.1016\/j.ijpddr.2016.12.005_bib35","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1021\/acs.jmedchem.5b01478","article-title":"Structure-based design and synthesis of novel inhibitors targeting HDAC8 from Schistosoma mansoni for the treatment of schistosomiasis","volume":"59","author":"Heimburg","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"issue":"7243","key":"10.1016\/j.ijpddr.2016.12.005_bib36","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature07829","article-title":"Histone modifications at human enhancers reflect global cell-type-specific gene expression","volume":"459","author":"Heintzman","year":"2009","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.ijpddr.2016.12.005_bib37","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0001-706X(93)90083-N","article-title":"A\u00a0comparison of three methods of estimating EC50 in studies of drug resistance of malaria parasites","volume":"55","author":"Huber","year":"1993","journal-title":"Acta Trop."},{"issue":"10","key":"10.1016\/j.ijpddr.2016.12.005_bib38","doi-asserted-by":"crossref","first-page":"793","DOI":"10.2146\/ajhp090247","article-title":"Vorinostat: a novel therapy for the treatment of cutaneous T-cell lymphoma","volume":"67","author":"Kavanaugh","year":"2010","journal-title":"Am. J. Health Syst. Pharm."},{"issue":"Database issue","key":"10.1016\/j.ijpddr.2016.12.005_bib39","doi-asserted-by":"crossref","first-page":"D387","DOI":"10.1093\/nar\/gkn750","article-title":"The SWISS-MODEL Repository and associated resources","volume":"37","author":"Kiefer","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ijpddr.2016.12.005_bib40","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1038\/ncomms2612","article-title":"Expansion of host cellular niche can drive adaptation of a zoonotic malaria parasite to humans","volume":"4","author":"Lim","year":"2013","journal-title":"Nat. Commun."},{"issue":"9859","key":"10.1016\/j.ijpddr.2016.12.005_bib41","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/S0140-6736(12)61728-0","article-title":"Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Lozano","year":"2012","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.ijpddr.2016.12.005_bib42","doi-asserted-by":"crossref","first-page":"e1003645","DOI":"10.1371\/journal.ppat.1003645","article-title":"Structural basis for the inhibition of histone deacetylase 8 (HDAC8), a key epigenetic player in the blood fluke Schistosoma mansoni","volume":"9","author":"Marek","year":"2013","journal-title":"PLoS Pathog."},{"issue":"6","key":"10.1016\/j.ijpddr.2016.12.005_bib43","doi-asserted-by":"crossref","first-page":"783","DOI":"10.4155\/fmc.15.25","article-title":"Drugging the schistosome zinc-dependent HDACs: current progress and future perspectives","volume":"7","author":"Marek","year":"2015","journal-title":"Future Med. Chem."},{"issue":"3","key":"10.1016\/j.ijpddr.2016.12.005_bib44","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1128\/AAC.01220-10","article-title":"Ex\u00a0vivo activity of histone deacetylase inhibitors against multidrug-resistant clinical isolates of Plasmodium falciparum and P.\u00a0vivax","volume":"55","author":"Marfurt","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2016.12.005_bib45","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/1756-3305-5-165","article-title":"Development of an in\u00a0vitro drug screening assay using Schistosoma haematobium schistosomula","volume":"5","author":"Marxer","year":"2012","journal-title":"Parasit. Vectors"},{"key":"10.1016\/j.ijpddr.2016.12.005_bib46","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.jmgm.2015.10.006","article-title":"Homology modeling of parasite histone deacetylases to guide the structure-based design of selective inhibitors","volume":"62","author":"Melesina","year":"2015","journal-title":"J.\u00a0Mol. Graph Model"},{"key":"10.1016\/j.ijpddr.2016.12.005_bib47","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.gene.2005.10.022","article-title":"The malaria parasite Plasmodium falciparum histones: organization, expression, and acetylation","volume":"369","author":"Miao","year":"2006","journal-title":"Gene"},{"issue":"2","key":"10.1016\/j.ijpddr.2016.12.005_bib48","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/onc.2013.605","article-title":"Targeting the epigenetic machinery of cancer cells","volume":"34","author":"Montenegro","year":"2015","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.ijpddr.2016.12.005_bib49","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1073\/pnas.1216457110","article-title":"Adaptation of the genetically tractable malaria pathogen Plasmodium knowlesi to continuous culture in human erythrocytes","volume":"110","author":"Moon","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"9859","key":"10.1016\/j.ijpddr.2016.12.005_bib50","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/S0140-6736(12)61689-4","article-title":"Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Murray","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.ijpddr.2016.12.005_bib51","author":"Novartis"},{"key":"10.1016\/j.ijpddr.2016.12.005_bib52","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1186\/s13071-015-1233-3","article-title":"Fluorescence\/luminescence-based markers for the assessment of Schistosoma mansoni schistosomula drug assays","volume":"8","author":"Panic","year":"2015","journal-title":"Parasit. Vectors"},{"issue":"8","key":"10.1016\/j.ijpddr.2016.12.005_bib53","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1021\/jm801654y","article-title":"Identification and characterization of small molecule inhibitors of a class I histone deacetylase from Plasmodium falciparum","volume":"52","author":"Patel","year":"2009","journal-title":"J.\u00a0Med. Chem."},{"issue":"1","key":"10.1016\/j.ijpddr.2016.12.005_bib54","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.bmc.2009.10.042","article-title":"Antimalarial and antileishmanial activities of histone deacetylase inhibitors with triazole-linked cap group","volume":"18","author":"Patil","year":"2010","journal-title":"Bioorg Med. Chem."},{"issue":"7","key":"10.1016\/j.ijpddr.2016.12.005_bib55","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1111\/j.1462-5822.2011.01593.x","article-title":"Quantitative proteome profiling informs on phenotypic traits that adapt Leishmania donovani for axenic and intracellular proliferation","volume":"13","author":"Pescher","year":"2011","journal-title":"Cell Microbiol."},{"key":"10.1016\/j.ijpddr.2016.12.005_bib56","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.02851","article-title":"Global distribution maps of the leishmaniases","volume":"3","author":"Pigott","year":"2014","journal-title":"Elife"},{"issue":"5","key":"10.1016\/j.ijpddr.2016.12.005_bib57","doi-asserted-by":"crossref","first-page":"601","DOI":"10.2217\/fon.09.36","article-title":"Panobinostat (LBH589): a potent pan-deacetylase inhibitor with promising activity against hematologic and solid tumors","volume":"5","author":"Prince","year":"2009","journal-title":"Future Oncol."},{"issue":"13","key":"10.1016\/j.ijpddr.2016.12.005_bib58","doi-asserted-by":"crossref","first-page":"3509","DOI":"10.1158\/1078-0432.CCR-11-3144","article-title":"Romidepsin for cutaneous T-cell lymphoma","volume":"18","author":"Prince","year":"2012","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.ijpddr.2016.12.005_bib59","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0166-6851(96)02779-X","article-title":"Evidence of cross-contamination among laboratory lines of Plasmodium berghei","volume":"84","author":"Saul","year":"1997","journal-title":"Mol. Biochem. Parasitol."},{"issue":"2","key":"10.1016\/j.ijpddr.2016.12.005_bib60","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1128\/AAC.00840-06","article-title":"Synergistic interactions of the antiretroviral protease inhibitors saquinavir and ritonavir with chloroquine and mefloquine against Plasmodium falciparum in\u00a0vitro","volume":"51","author":"Skinner-Adams","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"issue":"7","key":"10.1016\/j.ijpddr.2016.12.005_bib61","doi-asserted-by":"crossref","first-page":"3849","DOI":"10.1128\/AAC.00030-12","article-title":"Antimalarial activity of the anticancer histone deacetylase inhibitor SB939","volume":"56","author":"Sumanadasa","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"issue":"2","key":"10.1016\/j.ijpddr.2016.12.005_bib62","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1517\/14656566.2015.973850","article-title":"An update on pharmacotherapy for leishmaniasis","volume":"16","author":"Sundar","year":"2015","journal-title":"Expert Opin. Pharmacother."},{"issue":"5","key":"10.1016\/j.ijpddr.2016.12.005_bib63","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1093\/infdis\/jiu491","article-title":"Independent emergence of artemisinin resistance mutations among Plasmodium falciparum in Southeast Asia","volume":"211","author":"Takala-Harrison","year":"2015","journal-title":"J.\u00a0Infect. Dis."},{"issue":"16","key":"10.1016\/j.ijpddr.2016.12.005_bib64","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.2146\/news140056","article-title":"Belinostat approved for use in treating rare lymphoma","volume":"71","author":"Thompson","year":"2014","journal-title":"Am. J. Health Syst. Pharm."},{"issue":"4","key":"10.1016\/j.ijpddr.2016.12.005_bib65","doi-asserted-by":"crossref","first-page":"e84","DOI":"10.1371\/journal.pbio.1000084","article-title":"Sir2 paralogues cooperate to regulate virulence genes and antigenic variation in Plasmodium falciparum","volume":"7","author":"Tonkin","year":"2009","journal-title":"PLoS Biol."},{"issue":"4254","key":"10.1016\/j.ijpddr.2016.12.005_bib66","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1126\/science.781840","article-title":"Human malaria parasites in continuous culture","volume":"193","author":"Trager","year":"1976","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.ijpddr.2016.12.005_bib67","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1128\/AAC.02721-13","article-title":"Lysine acetylation in sexual stage malaria parasites is a target for antimalarial small molecules","volume":"58","author":"Trenholme","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"issue":"5","key":"10.1016\/j.ijpddr.2016.12.005_bib68","doi-asserted-by":"crossref","first-page":"e2226","DOI":"10.1371\/journal.pntd.0002226","article-title":"Dual targeting of insulin and venus kinase Receptors of Schistosoma mansoni for novel anti-schistosome therapy","volume":"7","author":"Vanderstraete","year":"2013","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"23","key":"10.1016\/j.ijpddr.2016.12.005_bib69","doi-asserted-by":"crossref","first-page":"7080","DOI":"10.1016\/j.bmcl.2010.09.096","article-title":"Antimalarial histone deacetylase inhibitors containing cinnamate or NSAID components","volume":"20","author":"Wheatley","year":"2010","journal-title":"Bioorg Med. Chem. Lett."},{"key":"10.1016\/j.ijpddr.2016.12.005_bib70","series-title":"World Malaria Report","author":"World Health Organization","year":"2015"},{"key":"10.1016\/j.ijpddr.2016.12.005_bib71","series-title":"The Global Burden of Disease: 2004 Update","author":"World Health Organization","year":"2008"},{"issue":"2","key":"10.1016\/j.ijpddr.2016.12.005_bib72","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/bmc.734","article-title":"Development and validation of high-performance liquid chromatography-tandem mass spectrometry assay for 6-(3-benzoyl-ureido)-hexanoic acid hydroxyamide, a novel HDAC inhibitor, in mouse plasma for pharmacokinetic studies","volume":"21","author":"Yeo","year":"2007","journal-title":"Biomed. Chromatogr."},{"issue":"20","key":"10.1016\/j.ijpddr.2016.12.005_bib73","doi-asserted-by":"crossref","first-page":"3885","DOI":"10.1007\/s00018-014-1656-6","article-title":"Histone deacetylase inhibitors and cell death","volume":"71","author":"Zhang","year":"2014","journal-title":"Cell Mol. Life Sci."}],"container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320716301117?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320716301117?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:47:26Z","timestamp":1761922046000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211320716301117"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":74,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S2211320716301117"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpddr.2016.12.005","relation":{},"ISSN":["2211-3207"],"issn-type":[{"value":"2211-3207","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of clinically approved HDAC inhibitors on Plasmodium, Leishmania and Schistosoma parasite growth","name":"articletitle","label":"Article Title"},{"value":"International Journal for Parasitology: Drugs and Drug Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpddr.2016.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Ltd on behalf of Australian Society for Parasitology.","name":"copyright","label":"Copyright"}]}}